Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001172661-25-001226·ARMISTICE CAPITAL, LLC
Schedule 13G ownership disclosure
QUOIN PHARMACEUTICALS LTD
American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S · CUSIP: 74907L300
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Armistice Capital, LLC
Shares: 934,312.00 · Class: 9.99%
- Steven Boyd
Shares: 934,312.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-001226
- Form type
- SCHEDULE 13G
- Filer
- ARMISTICE CAPITAL, LLC
- CIK
- CIK 1601086
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership